Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders

Details for Australian Patent Application No. 2006271682 (hide)

Owner Merck Serono SA

Inventors Jorand-Lebrun, Catherine; Gerber, Patrick; Bombrun, Agnes; Hooft Van Huijsduijnen, Rob; Vitte, Pierre-Alain

Agent Griffith Hack

Pub. Number AU-B-2006271682

PCT Pub. Number WO2007/009959

Priority 05106547.2 15.07.05 EP; 60/706,365 08.08.05 US

Filing date 14 July 2006

Wipo publication date 25 January 2007

Acceptance publication date 5 July 2012

International Classifications

A61K 31/192

A61K 31/195

A61K 31/196

A61K 31/404

A61K 31/452 - Piperidinium derivatives

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2007/009959 Priority application(s): WO2007/009959

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

5 July 2012 Application Accepted

  Published as AU-B-2006271682

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006271692-Combined use of metconazole and epoxiconazole for reducing or preventing the contamination of cereals with mycotoxins

2006271680-Toughened compositon